Skip to main content
Erschienen in: Pathology & Oncology Research 3/2017

28.10.2016 | Original Article

More Cases of Benign Testicular Teratomas are Detected in Adults than in Children. A Clinicopathological Study of 543 Testicular Germ Cell Tumor Cases

verfasst von: Semjén David, Farkas András, Kalman Endre, Kaszas Balint, Kovács Árpad, Pusztai Csaba, Szuhai Karoly, Tornóczky Tamás

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Benign testicular teratomas are always thought to be pediatric neoplasms and previously all the teratoid tumors in the adult testis regarded as malignant. Recently, three publications reported benign testicular teratomas in adulthood and the latest WHO classification refers them as “prepubertal type of teratomas” which rarely appear in adulthood. These neoplasms behave benign and seemingly analogous independently whether they appear in pre- or postpubertal patients. The aim of our study was to investigate the frequency of benign testicular teratomas both in children and adults. 593 cases of testicular neoplasms were found in a period of 17 years ranging from 1998 to 2014 in the archive of our department (Department of Pathology, Medical Center, Pécs University). 543 cases diagnosed as germ cell tumor which have all been further evaluated in conjunction with the clinical data available. Of all germ cell tumor cases 14 (2.5 %) were pure teratomas. Ten out of 14 were the WHO-defined “conventional” teratoma, 4 of the 14 were the “benign or the so called prepubertal type” from which three occurred in adult patients. Only one of the 14 occurred in childhood, indicating that benign prepubertal type teratomas –which are regarded generally as childhood tumors- are more frequently detected in adults than in children. Benign adult testicular teratomas comprised 21 % of all pure teratoma cases in our series. Practicioners in the field have to be aware of its existence also in adulthood to avoid overtreatment and not to expose their patients to unnecessary chemotherapy, retroperitoneal lymphadenectomy (RLA) and the potential complications of these interventions.
Literatur
1.
Zurück zum Zitat Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol 70(1):93–105CrossRefPubMed Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol 70(1):93–105CrossRefPubMed
2.
Zurück zum Zitat Srigley JR, Mackay B, Toth P, Ayala A (1988) The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruct Pathol 12(1):67–86CrossRefPubMed Srigley JR, Mackay B, Toth P, Ayala A (1988) The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruct Pathol 12(1):67–86CrossRefPubMed
3.
Zurück zum Zitat Zhang C, Berney DM, Hirsch MS, Cheng L, Ulbright TM (2013) Evidence supporting the existence of benign teratomas of the postpubertal testis a clinical, histopathologic, and molecular genetic analysis of 25 cases. Am J Surg Pathol 37(6):827–835CrossRefPubMed Zhang C, Berney DM, Hirsch MS, Cheng L, Ulbright TM (2013) Evidence supporting the existence of benign teratomas of the postpubertal testis a clinical, histopathologic, and molecular genetic analysis of 25 cases. Am J Surg Pathol 37(6):827–835CrossRefPubMed
4.
Zurück zum Zitat Semjen D, Kalman E, Tornoczky T, Szuhai K (2014) Further evidence of the existence of benign teratomas of the postpubertal testis. Am J Surg Pathol 38(4):580–581PubMed Semjen D, Kalman E, Tornoczky T, Szuhai K (2014) Further evidence of the existence of benign teratomas of the postpubertal testis. Am J Surg Pathol 38(4):580–581PubMed
5.
Zurück zum Zitat Oosterhuis JW, Stoop JA, Rijlaarsdam MA, Biermann K, Smit VT, Hersmus R, Looijenga LH (2015) Pediatric germ cell tumors presenting beyond childhood? Andrology 3(1):70–77. doi:10.1111/andr.305 CrossRefPubMed Oosterhuis JW, Stoop JA, Rijlaarsdam MA, Biermann K, Smit VT, Hersmus R, Looijenga LH (2015) Pediatric germ cell tumors presenting beyond childhood? Andrology 3(1):70–77. doi:10.​1111/​andr.​305 CrossRefPubMed
6.
Zurück zum Zitat Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293–300CrossRefPubMed Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293–300CrossRefPubMed
7.
Zurück zum Zitat Classen J, Schmidberger H, Meisner C, Souchon R, Sautter-Bihl M-L, Sauer R et al (2003) Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 21:1101–1106CrossRefPubMed Classen J, Schmidberger H, Meisner C, Souchon R, Sautter-Bihl M-L, Sauer R et al (2003) Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 21:1101–1106CrossRefPubMed
8.
Zurück zum Zitat Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ et al (2007) Incidence of metastatic non seminomatous germ cell tumor outside the boundaries of a modified post chemotherapy retroperitoneal lymph node dissection. J Clin Oncol 25:4365–4369CrossRefPubMed Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ et al (2007) Incidence of metastatic non seminomatous germ cell tumor outside the boundaries of a modified post chemotherapy retroperitoneal lymph node dissection. J Clin Oncol 25:4365–4369CrossRefPubMed
9.
Zurück zum Zitat Fischer CG, Waechter W, Kraus S, Fuentecilla Perez E, Weidner W et al (1998) Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer 82(4):775–783CrossRefPubMed Fischer CG, Waechter W, Kraus S, Fuentecilla Perez E, Weidner W et al (1998) Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer 82(4):775–783CrossRefPubMed
10.
Zurück zum Zitat Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Søgaard H et al (1984) Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases. Krag Acta Radiol Oncol 23(4):239–247CrossRef Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Søgaard H et al (1984) Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases. Krag Acta Radiol Oncol 23(4):239–247CrossRef
11.
Zurück zum Zitat D.E. Cooper, J.O. L'Esperance, M.S. Christman, B.K. Auge (2008) Testis Cancer: a 20-year Epidemiological Review of the Experience at a Regional Military Medical Facility Adult Urology J Urol, 180(2):577–581; discussion 581-2. doi:10.1016/j.juro.2008.04.032 D.E. Cooper, J.O. L'Esperance, M.S. Christman, B.K. Auge (2008) Testis Cancer: a 20-year Epidemiological Review of the Experience at a Regional Military Medical Facility Adult Urology J Urol, 180(2):577–581; discussion 581-2. doi:10.​1016/​j.​juro.​2008.​04.​032
12.
Zurück zum Zitat Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5(3):210–222CrossRefPubMed Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5(3):210–222CrossRefPubMed
Metadaten
Titel
More Cases of Benign Testicular Teratomas are Detected in Adults than in Children. A Clinicopathological Study of 543 Testicular Germ Cell Tumor Cases
verfasst von
Semjén David
Farkas András
Kalman Endre
Kaszas Balint
Kovács Árpad
Pusztai Csaba
Szuhai Karoly
Tornóczky Tamás
Publikationsdatum
28.10.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2017
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0120-3

Weitere Artikel der Ausgabe 3/2017

Pathology & Oncology Research 3/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.